<?xml version="1.0" encoding="UTF-8"?>
<p>Cotrimoxazole prevention therapy should be provided to all patients with HIV infection. No significant interaction has been observed with any second-line anti-TB agents. Strict monitoring of ADRs is indispensable, as there are overlapping toxicities among ART, anti-TB, therapy, and cotrimoxazole prevention therapy.</p>
